Feasibility of protein-sparing modified fast by tube (ProMoFasT) in obesity treatment: a phase II pilot trial on clinical safety and efficacy (appetite control, body composition, muscular strength, metabolic pattern, pulmonary function test)

Anecdotal data in the last few years suggest that protein-sparing modified diet (PSMF) delivered by naso-gastric tube enteral (with continuous feeding) could attain an significant weight loss and control of appetite oral feeding, but no phase II studies on safety and efficacy have been done up to no...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukkar, S. G., Signori, A., Borrini, C., Barisione, G., Ivaldi, C., Romeo, C., Gradaschi, R., Machello, N., Nanetti, E., Vaccaro, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764321/
https://www.ncbi.nlm.nih.gov/pubmed/24027606
http://dx.doi.org/10.1007/s12349-013-0126-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764321/
https://www.ncbi.nlm.nih.gov/pubmed/24027606
http://dx.doi.org/10.1007/s12349-013-0126-2

Ejemplares similares